Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial

BACKGROUND: Low-dose naltrexone (LDN) is used widely as an off-label treatment for pain despite limited evidence for its effectiveness. A few small trials with a high risk of bias have investigated the effect of LDN on pain associated with fibromyalgia in women, but larger and more methodologically...

Descripción completa

Detalles Bibliográficos
Autores principales: Bruun, Karin Due, Amris, Kirstine, Vaegter, Henrik Bjarke, Blichfeldt-Eckhardt, Morten Rune, Holsgaard-Larsen, Anders, Christensen, Robin, Toft, Palle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591911/
https://www.ncbi.nlm.nih.gov/pubmed/34781989
http://dx.doi.org/10.1186/s13063-021-05776-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591911/
https://www.ncbi.nlm.nih.gov/pubmed/34781989
http://dx.doi.org/10.1186/s13063-021-05776-7

Ejemplares similares